Literature DB >> 16488334

The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approach.

Kenneth B Gordon1, Eric M Ruderman.   

Abstract

Psoriatic arthritis is a common inflammatory arthritis associated with psoriasis, occurring in 5% to 40% of patients with cutaneous disease. Recently, there has been an increased appreciation of the need to use an integrated approach to these 2 diseases, considering both entities when determining therapeutic choices. In this review, the available therapeutic options for psoriatic arthritis are considered, along with the potential benefit that these medications may have for cutaneous psoriasis. Finally, a conceptual model for the therapy of psoriasis and psoriatic arthritis, the Four Quadrant Model, is presented as a simplified framework to use when considering treatment for psoriatic disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16488334     DOI: 10.1016/j.jaad.2005.10.052

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  9 in total

1.  Which Psoriasis Patients Develop Psoriatic Arthritis?

Authors:  Kristine Busse; Wilson Liao
Journal:  Psoriasis Forum       Date:  2010

2.  Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic.

Authors:  Michele Maria Luchetti; Devis Benfaremo; Anna Campanati; Elisa Molinelli; Monia Ciferri; Serena Cataldi; William Capeci; Marco Di Carlo; Anna Maria Offidani; Fausto Salaffi; Armando Gabrielli
Journal:  Clin Rheumatol       Date:  2018-07-29       Impact factor: 2.980

3.  Patient characteristics, treatment patterns and disease outcomes in patients with psoriatic arthritis followed in a combined Dermatology-Rheumatology clinic: a retrospective real-world study.

Authors:  Kalliopi Klavdianou; Maria Stavropoulou; Pantelis Panagakis; Marina Papoutsaki; Alexandros Panagiotopoulos; Christos Koutsianas; Alexandros Stratigos; Dimitrios Rigopoulos; Dimitrios Vassilopoulos
Journal:  Rheumatol Int       Date:  2022-04-18       Impact factor: 2.631

Review 4.  Etanercept: a review of its use in the management of ankylosing spondylitis and psoriatic arthritis.

Authors:  Sheridan M Hoy; Lesley J Scott
Journal:  Drugs       Date:  2007       Impact factor: 9.546

5.  Analysis of the Potential Topical Anti-Inflammatory Activity of Averrhoa carambola L. in Mice.

Authors:  Daniela Almeida Cabrini; Henrique Hunger Moresco; Priscila Imazu; Cíntia Delai da Silva; Evelise Fernandes Pietrovski; Daniel Augusto Gasparin Bueno Mendes; Arthur da Silveira Prudente; Moacir Geraldo Pizzolatti; Inês Maria Costa Brighente; Michel Fleith Otuki
Journal:  Evid Based Complement Alternat Med       Date:  2011-05-02       Impact factor: 2.629

6.  Biological markers in the etiology of psoriasis: Targeted treatment options.

Authors:  Catia de Felice; Georgiana Clare Marulli; Marco Ardigò; Enzo Berardesca
Journal:  Biologics       Date:  2007-03

Review 7.  Treatment recommendations for psoriatic arthritis.

Authors:  C T Ritchlin; A Kavanaugh; D D Gladman; P J Mease; P Helliwell; W-H Boehncke; K de Vlam; D Fiorentino; O Fitzgerald; A B Gottlieb; N J McHugh; P Nash; A A Qureshi; E R Soriano; W J Taylor
Journal:  Ann Rheum Dis       Date:  2008-10-24       Impact factor: 19.103

8.  Design, synthesis and in vitro degradation of a novel co-drug for the treatment of psoriasis.

Authors:  Wing Man Lau; Charles M Heard; Alex W White
Journal:  Pharmaceutics       Date:  2013-04-17       Impact factor: 6.321

9.  Towards a combined pediatric rheumatology-dermatology clinic: One-year experience.

Authors:  Fatma Gul Demirkan; Zeynep Topkarci; Serife Gul Karadag; Hafize Emine Sonmez; Figen Cakmak; Nuray Aktay Ayaz
Journal:  North Clin Istanb       Date:  2020-11-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.